ASND Ascendis Pharma A/S
Price Chart
Executive Summary
CFO Scott Thomas and Director Jean-Jacques Bienaimé made open-market purchases totaling $67K over a 5-day window. While the dollar amount is trivial relative to ASND's $13.6B market cap (0.0005%), cluster buys — especially involving C-suite — carry asymmetric informational weight per the academic literature. The purchases occurred without any accompanying 10b5-1 pattern, suggesting voluntary conviction.
Key Financial Metrics
Actionable Insight
The cluster is too small to drive stock price action on its own, but CFO buying alongside a director signals management's confidence ahead of upcoming catalysts (likely TransCon PTH data or Skytrofa updates). Monitor for additional insider purchases or a material 8-K in the next 2-4 weeks. The historical calibration shows ASND insider-buy signals have underperformed (avg T+20 alpha -7.3%), so treat this as a modest positive signal, not a trade trigger.
Key Facts
- CFO Scott Thomas purchased 350 shares total ($77.7K) across two separate open-market transactions on May 29 and June 2.
- Director Jean-Jacques Bienaimé purchased 200 shares ($44.8K) on May 29.
- Total cluster value of $122.5K is 0.0009% of ASND's $13.6B market cap — well below the 0.1% materiality threshold.
- No 10b5-1 plan or vesting-driven pattern detected; both transactions are voluntary open-market buys.
- ASND has 96% analyst bullish consensus (23 of 24 analysts at Buy/Strong Buy).
Financial Impact
Total insider purchases of $122.5K represent ~0.0009% of market cap — economically trivial in absolute terms.
Risk Factors
- Historical calibration shows ASND insider-buy signals have delivered negative average alpha at T+20 (-7.3% vs SPY).
- Dollar amount is too small to overcome the company's $13.6B market cap — institutional flows dominate.
- No accompanying corporate event (earnings, pipeline update) to contextualize the buying.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ASND-1780431963004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 13, 2026
1d ago
|
Press Release
| — | awaiting T+1 | — | — |
|
Jun 12, 2026
2d ago
|
6-K
| $215.32 awaiting T+1 | awaiting T+1 | — | $218.06 (+1.27%) |
|
Jun 2, 2026
12d ago
|
Insider Cluster
| $216.79 $218.84 | ▲ +0.95% | ▲ +0.55% | $218.06 (+0.59%) |
|
May 19, 2026
26d ago
|
ANALYST-UPGRADE
| $237.98 $241.34 | ▲ +1.41% | ▲ +0.37% | $218.06 (−8.37%) |
|
May 16, 2026
29d ago
|
ANALYST-UPGRADE
| $170.74 $162.84 | ▼ −4.63% | ▼ −3.78% | $218.06 (+27.71%) |
|
May 7, 2026
5w ago
|
6-K
| $246.14 $238.66 | ▼ −3.04% | ▼ −3.87% | $218.06 (−11.41%) |
|
May 7, 2026
5w ago
|
6-K
| $246.14 $238.66 | ▼ −3.04% | ▼ −3.87% | $218.06 (−11.41%) |
|
May 6, 2026
5w ago
|
Press Release
| $246.14 $246.14 | · 0.00% | ▼ −0.83% | $218.06 (−11.41%) |
|
Apr 21, 2026
7w ago
|
6-K
| $240.29 $231.05 | ▼ −3.85% | ▼ −4.86% | $218.06 (−9.25%) |
|
Apr 16, 2026
8w ago
|
ANALYST-UPGRADE
| $242.95 $244.48 | ▲ +0.63% | ▼ −0.58% | $218.06 (−10.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access